217 related items for PubMed ID: 3216557
1. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K, Sakai S, Miyahara T.
Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1153-60. PubMed ID: 3216557
[No Abstract] [Full Text] [Related]
2. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K, Sakai S, Miyahara T.
Prog Clin Biol Res; 1990 Sep; 337():193-4. PubMed ID: 2191313
[No Abstract] [Full Text] [Related]
3. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S.
Nephrol Dial Transplant; 1994 Sep; 9(3):257-64. PubMed ID: 8052431
[Abstract] [Full Text] [Related]
4. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
Miyazono M, Tomiyoshi Y, Kishi T, Ikeda Y, Sakemi T, Sanai T, Node K.
Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
[Abstract] [Full Text] [Related]
5. Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis.
Araki H, Ono S, Nishizawa Y, Deji N, Nakazawa J, Morita Y, Kume S, Chin-Kanasaki M, Isshiki K, Araki S, Arimura T, Maegawa H, Uzu T.
Intern Med; 2015 Aug; 54(17):2213-7. PubMed ID: 26328649
[Abstract] [Full Text] [Related]
6. LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy.
Yokoyama K, Sakai S, Sigematsu T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T.
Clin Nephrol; 1998 Jul; 50(1):1-7. PubMed ID: 9710340
[Abstract] [Full Text] [Related]
7. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
Iwahori T, Yoshida M, Sugiura M, Ioya N, Kawaguchi M.
Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
[Abstract] [Full Text] [Related]
8. Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.
Kawasaki Y, Suzuki S, Matsumoto A, Takano K, Suyama K, Hashimoto K, Suzuki J, Suzuki H, Hosoya M.
Pediatr Nephrol; 2007 Jun; 22(6):889-92. PubMed ID: 17277952
[Abstract] [Full Text] [Related]
9. An update on LDL apheresis for nephrotic syndrome.
Raina R, Krishnappa V.
Pediatr Nephrol; 2019 Oct; 34(10):1655-1669. PubMed ID: 30218191
[Abstract] [Full Text] [Related]
10. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
Sakurai M, Muso E, Matushima H, Ono T, Sasayama S.
Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
[Abstract] [Full Text] [Related]
11. Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis.
Hattori M, Ito K, Kawaguchi H, Tanaka T, Kubota R, Khono M.
Pediatr Nephrol; 1993 Apr; 7(2):196-8. PubMed ID: 8476719
[Abstract] [Full Text] [Related]
12. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
Oto J, Suga K, Matsuura S, Kondo S, Ohnishi Y, Inui D, Imanaka H, Kagami S, Nishimura M.
J Anesth; 2009 Apr; 23(2):284-7. PubMed ID: 19444573
[Abstract] [Full Text] [Related]
13. Complete remission of the nephrotic syndrome due to focal glomerular sclerosis achieved with low density lipoprotein adsorption alone.
Yokoyama K, Sakai S, Yamaguchi Y, Suzuki Y, Hinoshita F, Hara S, Yamada A, Ogura Y, Kawaguchi Y, Sakai O.
Nephron; 1996 Apr; 72(2):318-20. PubMed ID: 8684548
[No Abstract] [Full Text] [Related]
14. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K.
Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182
[Abstract] [Full Text] [Related]
15. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS).
Muso E, Mune M, Yorioka N, Nishizawa Y, Hirano T, Hattori M, Sugiyama S, Watanabe T, Kimura K, Yokoyama H, Sato H, Saito T.
Clin Nephrol; 2007 Jun; 67(6):341-4. PubMed ID: 17598368
[Abstract] [Full Text] [Related]
16. [Refractory nephrotic syndrome].
Saito T.
Nihon Rinsho; 2004 Oct; 62(10):1794-9. PubMed ID: 15500120
[Abstract] [Full Text] [Related]
17. [A case of focal segmental glomerulosclerosis(FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis].
Takaki A, Nakatsuka A, Satou C, Iwata Y, Ikeda H, Fukushima M.
Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):806-12. PubMed ID: 12607970
[Abstract] [Full Text] [Related]
18. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.
Clin Nephrol; 2006 Jan; 65(1):1-6. PubMed ID: 16429835
[Abstract] [Full Text] [Related]
19. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Miki S, Kuwahara T, Takamitsu Y, Takemura T, Tsubakihara Y.
Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
[Abstract] [Full Text] [Related]
20. Blood level of cyclosporin [correction of cyclospolin] during LDL-apheresis in nephrotic syndrome patients.
Nakajima F, Shibahara N, Ijiri Y, Ashida A, Ueda H, Katsuoka Y.
J Clin Apher; 1999 Jul; 14(4):193-4. PubMed ID: 10611632
[No Abstract] [Full Text] [Related]
Page: [Next] [New Search]
